What Researchers Did
Researchers reviewed studies on hyperbaric oxygen therapy (HBOT), topical oxygen therapy (TOT), and Oxyzyme™ for healing chronic wounds, particularly in patients with diabetes.
What They Found
The review found that therapeutic oxygen aids in the healing of chronic wounds, with clear benefits observed from both Hyperbaric Oxygen Therapy (HBOT) and Topical Oxygen Therapy (TOT). While a new portable topical oxygen delivery system, Oxyzyme™, shows potential, its use is still embryonic, and studies on its effectiveness are limited, requiring more robust efficacy measures.
What This Means for Canadian Patients
Canadian patients suffering from chronic, non-healing wounds, particularly those with diabetes, may benefit from established oxygen-associated therapies like Hyperbaric Oxygen Therapy and Topical Oxygen Therapy. These therapies offer potential avenues for improved wound healing outcomes, though newer options like Oxyzyme™ require further research before widespread clinical adoption.
Canadian Relevance
This review does not have a direct Canadian connection as it focuses on general therapeutic approaches to wound healing.
Study Limitations
A key limitation highlighted is the embryonic stage and limited studies on the effectiveness of the new Oxyzyme™ therapy, necessitating more robust efficacy measures.